Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

A Look into the Future of Chronic Pain Management

An Interview with Innocan Pharma’s CEO, Iris Bincovich. Innocan Pharma is gaining attention for its innovative pain relief solutions — particularly through its slow-release injection technology. This cutting-edge approach delivers synthetic Cannabidi...

Expert advises to invest 'wherever value takes you' after rate cut

Allan Small, a senior investment advisor of the Allan Small Financial Group with iA Private Wealth, joins Coreena Robertson in the Expert Exchange to analyze the Bank of Canada’s recent decision to cut interest rates by 50 basis points, the fourth cut th...

Leading Edge Materials: Positioning for the EU’s critical minerals push

By David Yeoman, Crux Investor Leading Edge Materials has a portfolio of critical raw materials projects in the EU, including the Norra Kärr heavy rare earths project in Sweden, the Woxna graphite mine in Sweden, and an exploration program in Romania. ...

Wise investment moves to recession proof your portfolio

Robert G. Gill, senior vice president and portfolio manager at Goodreid Investment Counsel joins The Market Online to discuss recession proofing your portfolio. “A recession is an excellent time to upgrade the quality of your portfolio.”...

Is Lululemon a buy, sell or hold?

Lululemon Athletica Inc. (NDAQ: LULU) has seen a recent dip in its share price, declining to its lowest level in four years one day before the company’s 2024 Summer Olympic apparel debuted on Team Canada athletes in the opening ceremonies of Paris 2024...

A world-class copper opportunity in Peru

The following is a transcription of the above video, and The Market Online has edited it for clarity . The Market Online recently caught up with Ivan Bebek, the co-founder and CEO of Coppernico Metals Inc , a mineral exploration company focused on creating value for...

Lower inflation primes Canada's real estate market for a shift

June’s inflation rate reduced to 2.7 percent from 2.9 percent in May, giving the BOC a reason to lower the current policy interest rate. On June 5 the Bank of Canada lowered the interest rate 25 basis points to 4.75 per cent, and experts are betting on ano...

Leading Edge raising C$4.5M to supply European critical raw materials

Leading Edge Materials is offering a C$4.5 million non-brokered private placement Proceeds will be used to fund the company’s projects in Sweden and Romania The company has a 100 per cent stake in its Woxna Graphite Mine and Norra Karr ...

Canadian Bitcoin portal stresses accessibility and independence

The Bitcoin world has experienced vast and rapid advancements, transforming from a niche digital currency into a mainstream financial asset. From its inception as a decentralized form of money, Bitcoin has evolved into a dynamic ecosystem, driving innovation in block...

NervGen: Are amazing human trial results leaking out?

“We are very excited! We are very, very excited!” So says Dr. Monica Perez, who is running the first human trial for a potential new wonder drug being developed by a tiny but well-financed life sciences start-up, NervGen Pharma Corp. ...
1 2 3 4 5 6 7 8 9 10 ...